Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity

April K Marrone1, Frederick A Beland, Igor P Pogribny

  • 1Commissioner Fellow, Research Chemist,National Center for Toxicological Research, Division of Biochemical Toxicology , Jefferson, AR , USA.

Abstract

Insights

Environmental chemical exposure increases cancer risk. Noncoding RNAs (ncRNAs) are altered by toxicants, offering potential for early cancer detection and toxicity assessment.

Area of Science:

  • Toxicogenomics
  • Molecular Toxicology
  • Cancer Research

Background:

  • Chemicals, including environmental and occupational exposures, are significant risk factors for noncommunicable diseases, particularly cancer.
  • Sustained cellular stress from carcinogen/toxicant exposure, marked by nongenotoxic events, contributes to tumorigenesis and is regulated by noncoding RNAs (ncRNAs).
  • Altered ncRNA expression due to genotoxic and nongenotoxic events provides a mechanistic link between chemical exposure and cancer development, with toxicogenomics offering insights into gene-chemical interactions.

Purpose of the Study:

  • To review the impact of xenobiotics (foreign chemical substances) on ncRNAs.
  • To highlight the critical role of ncRNAs in cellular responses to carcinogen and toxicant exposure.

Main Methods:

  • Literature review summarizing recent findings on xenobiotics and ncRNAs.
  • Analysis of evidence demonstrating the involvement of ncRNAs in toxicant-induced cellular events.

Main Results:

  • Xenobiotics significantly impact the expression and function of ncRNAs.
  • ncRNAs play a crucial role in mediating cellular responses to chemical carcinogens and toxicants.
  • Toxicogenomic approaches reveal complex gene-chemical interactions at the transcriptome level.

Conclusions:

  • ncRNAs exhibit tissue specificity, appear early, have low variability, and are stable in biological fluids.
  • Incorporating ncRNAs into cancer risk assessment can significantly improve the efficiency of toxicity and carcinogenicity testing.
  • ncRNAs hold promise as biomarkers for early disease detection and for evaluating the risks of new chemicals and drugs.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.4K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
198
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
219
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
228
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K